litlas
ログインアカウント作成

Michael J. Rybak

1988–2025 年に発表

174
論文数
30,408
被引用数
89
h 指数
170
i10 指数

被引用数

Michael J. Rybak の年別被引用数1980 年: 被引用 3 件1984 年: 被引用 1 件1989 年: 被引用 3 件1990 年: 被引用 4 件1991 年: 被引用 3 件1992 年: 被引用 9 件1993 年: 被引用 6 件1994 年: 被引用 11 件1995 年: 被引用 11 件1996 年: 被引用 14 件1997 年: 被引用 16 件1998 年: 被引用 19 件1999 年: 被引用 30 件2000 年: 被引用 37 件2001 年: 被引用 39 件2002 年: 被引用 33 件2003 年: 被引用 75 件2004 年: 被引用 75 件2005 年: 被引用 95 件2006 年: 被引用 80 件2007 年: 被引用 118 件2008 年: 被引用 104 件2009 年: 被引用 141 件2010 年: 被引用 118 件2011 年: 被引用 181 件2012 年: 被引用 185 件2013 年: 被引用 235 件2014 年: 被引用 191 件2015 年: 被引用 202 件2016 年: 被引用 196 件2017 年: 被引用 184 件2018 年: 被引用 160 件2019 年: 被引用 883 件2020 年: 被引用 906 件2021 年: 被引用 763 件2022 年: 被引用 747 件2023 年: 被引用 567 件2024 年: 被引用 977 件2025 年: 被引用 429 件2026 年: 被引用 6 件1981〜1983 年は被引用が無いため表示していません1985〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,171 件、この内訳の 28.6%中国: 引用元論文 520 件、この内訳の 6.9%イタリア: 引用元論文 382 件、この内訳の 5%イギリス: 引用元論文 351 件、この内訳の 4.6%オーストラリア: 引用元論文 320 件、この内訳の 4.2%フランス: 引用元論文 304 件、この内訳の 4%スペイン: 引用元論文 268 件、この内訳の 3.5%ドイツ: 引用元論文 247 件、この内訳の 3.3%カナダ: 引用元論文 216 件、この内訳の 2.8%インド: 引用元論文 201 件、この内訳の 2.7%オランダ: 引用元論文 171 件、この内訳の 2.3%日本: 引用元論文 168 件、この内訳の 2.2%
0%28.6%その他 29.9%

機関

分野

  • Medicine62.7%
  • Biochemistry, Genetics and Molecular Biology19.1%
  • Environmental Science6.5%
  • Immunology and Microbiology5.6%
  • Chemistry1.2%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • その他3.7%

トピック

  • Antimicrobial Resistance in Staphylococcus13.3%
  • Antibiotics Pharmacokinetics and Efficacy8.9%
  • Antibiotic Resistance in Bacteria8.3%
  • Bacterial Identification and Susceptibility Testing6.3%
  • Infective Endocarditis Diagnosis and Management4.8%
  • Antibiotic Use and Resistance3.5%
  • その他54.9%

共著者

全論文

検索で開く
  1. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

    著者: Larry M. Baddour, Walter R. Wilson, Arnold S. Bayer, Vance G. Fowler, Imad M. Tleyjeh, Michael J. Rybak, Bruno Baršić, Peter B. Lockhart, Michael H. Gewitz, Matthew E. Levison, Ann F. Bolger, James M. Steckelberg, Robert S. Baltimore, Anne Fink, Patrick T. O’Gara, Kathryn A. Taubert - Circulation 2015 被引用: 3,171

  2. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

    著者: Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove, Robert S. Daum, Scott K. Fridkin, Rachel Gorwitz, Sheldon L. Kaplan, Adolf W. Karchmer, Donald P. Levine, Barbara E. Murray, Michael J. Rybak, David A. Talan, Henry F. Chambers - Clinical Infectious Diseases 2011 被引用: 4,179

  3. Considerations for the Use of Phage Therapy in Clinical Practice

    著者: Gina A. Suh, Thomas P. Lodise, Pranita D. Tamma, Jane M. Knisely, Jose Alexander, Saima Aslam, Karen D. Barton, Erica Bizzell, Katherine M. C. Totten, Joseph L. Campbell, Benjamin K. Chan, Scott A. Cunningham, Katherine E. Goodman, Kerryl E. Greenwood-Quaintance, Anthony D. Harris, Shayla Hesse, Anthony Maresso, Veronique Nussenblatt, David Pride, Michael J. Rybak, Zoe Sund, David van Duin, Daria Van Tyne, Robin Patel, for the Antibacterial Resistance Leadership Group - Antimicrobial Agents and Chemotherapy 2022 被引用: 363

  4. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

    著者: Michael J. Rybak, Jennifer Lê, Thomas P. Lodise, Donald P. Levine, John S. Bradley, Catherine Liu, Bruce A. Mueller, Manjunath P. Pai, Annie Wong‐Beringer, John C. Rotschafer, Keith A. Rodvold, Holly Maples, Benjamin M. Lomaestro - American Journal of Health-System Pharmacy 2020 被引用: 1,133

  5. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

    著者: Ashlan J. Kunz Coyne, Amer El Ghali, Dana Holger, Nicholas Rebold, Michael J. Rybak - Infectious Diseases and Therapy 2022 被引用: 277

  6. The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin

    著者: Michael J. Rybak - Clinical Infectious Diseases 2005 被引用: 775

  7. Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

    著者: Keith S. Kaye, Dror Marchaim, Visanu Thamlikitkul, Yehuda Carmeli, Cheng‐Hsun Chiu, George L. Daikos, Sorabh Dhar, Emanuele Durante‐Mangoni, Achilleas Gikas, Αναστασία Κοτανίδου, Mical Paul, Emmanuelle Roilides, Michael J. Rybak, Michael Samarkos, Matthew Sims, Dora Tancheva, Sotirios Tsiodras, Daniel H. Kett, Gopi Patel, David P. Calfee, Leonard Leibovici, Laura E. Power, L. Silvia Muñoz-Price, Kurt Stevenson, Laura Susick, Katie Latack, Jolene Daniel, Christine C. Chiou, George Divine, Varduhi Ghazyaran, Jason M. Pogue - NEJM Evidence 2022 被引用: 143

  8. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

    著者: Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove, Robert S. Daum, Scott K. Fridkin, Rachel Gorwitz, Sheldon L. Kaplan, Adolf W. Karchmer, Donald P. Levine, Barbara E. Murray, Michael J. Rybak, David A. Talan, Henry F. Chambers - Clinical Infectious Diseases 2011 被引用: 1,599

  9. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

    著者: Michael J. Rybak, Ben M. Lomaestro, John C. Rotschafer, Robert C. Moellering, William A. Craig, Marianne Billeter, J. R. Dalovisio, Donald P. Levine - American Journal of Health-System Pharmacy 2008 被引用: 1,794

  10. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

    著者: Michael J. Rybak, Jennifer Lê, Thomas P. Lodise, Donald P. Levine, John S. Bradley, Catherine Liu, Bruce A. Mueller, Manjunath P. Pai, Annie Wong‐Beringer, John C. Rotschafer, Keith A. Rodvold, Holly Maples, Benjamin M. Lomaestro - Clinical Infectious Diseases 2020 被引用: 412

  11. A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis

    著者: Maya Beganovic, Megan K. Luther, Louis B. Rice, César A. Arias, Michael J. Rybak, Kerry L. LaPlante - Clinical Infectious Diseases 2018 被引用: 233

  12. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

    著者: Sandra Mikhail, Nivedita B. Singh, Razieh Kebriaei, Seth Rice, Kyle Stamper, Mariana Castanheira, Michael J. Rybak - Antimicrobial Agents and Chemotherapy 2019 被引用: 168

  13. Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations

    著者: Taylor Morrisette, Razieh Kebriaei, Katherine L. Lev, Sandra Morales, Michael J. Rybak - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2019 被引用: 99

  14. Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections

    著者: Amer El Ghali, Ashlan J. Kunz Coyne, Kaylee E Caniff, Callan Bleick, Michael J. Rybak - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2023 被引用: 54

  15. Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

    著者: Sarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, Abdalhamid M Lagnf, Sahil Bhatia, Sarah Melvin, Molly E. Steed, Samuel Simon, S. J. Estrada, Taylor Morrisette, Kimberly C. Claeys, Joshua Rosenberg, Susan L. Davis, Michael J. Rybak - Open Forum Infectious Diseases 2019 被引用: 137

  16. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms

    著者: Razieh Kebriaei, Susan M. Lehman, Rahi M. Shah, Kyle Stamper, Ashlan J. Kunz Coyne, Dana Holger, Amer El Ghali, Michael J. Rybak - Microbiology Spectrum 2023 被引用: 43

  17. Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

    著者: Michael J. Rybak, Ben M. Lomaestro, John C. Rotscahfer, Robert C. Moellering, Willam A. Craig, Marianne Billeter, J. R. Dalovisio, Donald P. Levine - Clinical Infectious Diseases 2009 被引用: 809

  18. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing

    著者: Dana Holger, Katherine L. Lev, Razieh Kebriaei, Taylor Morrisette, Rahi M. Shah, Jose Alexander, Susan M. Lehman, Michael J. Rybak - Journal of Applied Microbiology 2022 被引用: 45

  19. Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii

    著者: Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, Leonor M. Rojas, Madeline King, Benjamin Pullinger, Athena L V Hobbs, Nicholson B. Perkins, Michael P. Veve, Jeannette Bouchard, Tristan Gore, Bruce M Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S. Lena Kang‐Birken, Kyle C. Molina, Mark Biagi, Michael Pierce, Marco R. Scipione, Jing Zhao, Susan L. Davis, Michael J. Rybak - Microbiology Spectrum 2022 被引用: 54

  20. Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus

    著者: Razieh Kebriaei, Katherine L. Lev, Taylor Morrisette, Kyle Stamper, Jacinda C. Abdul‐Mutakabbir, Susan M. Lehman, Sandra Morales, Michael J. Rybak - Antimicrobial Agents and Chemotherapy 2020 被引用: 65

  21. The β‐Lactams Strike Back: Ceftazidime‐Avibactam

    著者: Evan J Zasowski, Jeffrey M. Rybak, Michael J. Rybak - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2015 被引用: 220

  22. Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination

    著者: Razieh Kebriaei, Katherine L. Lev, Rahi M. Shah, Kyle Stamper, Dana Holger, Taylor Morrisette, Ashlan J. Kunz Coyne, Susan M. Lehman, Michael J. Rybak - Microbiology Spectrum 2022 被引用: 44

  23. Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models

    著者: Dana Holger, Amer El Ghali, Natasha Bhutani, Katherine L. Lev, Kyle Stamper, Razieh Kebriaei, Ashlan J. Kunz Coyne, Taylor Morrisette, Rahi M. Shah, Jose Alexander, Susan M. Lehman, Laura J. Rojas, Steven H. Marshall, Robert A. Bonomo, Michael J. Rybak - Antimicrobial Agents and Chemotherapy 2023 被引用: 29

  24. Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments

    著者: Erin K McCreary, Ravina Kullar, Matthew Geriak, Evan J Zasowski, Khulood Rizvi, Lucas Schulz, Krista Ouellette, Logan Vasina, Fadi Haddad, Michael J. Rybak, Marcus Zervos, George Sakoulas, Warren E. Rose - Open Forum Infectious Diseases 2019 被引用: 90